Skip to main content

Ocimum to Provide Microarray Analysis for Hospital of Joint Diseases

NEW YORK, July 7 - Bioinformatics startup Ocimum Biosolutions said today that it is collaborating with the Hospital of Joint Diseases at New York University's School of Medicine to analyze musculoskeletal disease data.


Ocimum will use its microarray analysis software Genowiz in the project.


Financial terms and other details of the project were not disclosed.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.